Evidence map›Paper›PMID 31323138›Full record

ArticleImmunology2019

T-cell activation by transgenic rice seeds expressing the genetically modified Japanese cedar pollen allergens.

Shinya Takaishi, Saburo Saito, Tomonori Endo, Daiya Asaka, Yuhya Wakasa, Hidenori Takagi, Kenjiro Ozawa, Fumio Takaiwa, Nobuyoshi Otori, Hiromi Kojima

Abstract read
In one paragraph

Article in Immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shinya TakaishiDepartment of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.ORCID 0000-0003-4849-2975
Saburo SaitoDivision of Molecular Immunology, Research Center for Medical Sciences, Jikei University School of Medicine, Tokyo, Japan.
Tomonori EndoDepartment of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.
Daiya AsakaDepartment of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.
Yuhya WakasaPlant Molecular Farming Unit, Division of Biotechnology, Institute of Agrobiological Sciences, National Agriculture and Food Research Organization, Ibaraki, Japan.
Hidenori TakagiPlant Molecular Farming Unit, Division of Biotechnology, Institute of Agrobiological Sciences, National Agriculture and Food Research Organization, Ibaraki, Japan.
Kenjiro OzawaPlant Molecular Farming Unit, Division of Biotechnology, Institute of Agrobiological Sciences, National Agriculture and Food Research Organization, Ibaraki, Japan.
Fumio TakaiwaPlant Molecular Farming Unit, Division of Biotechnology, Institute of Agrobiological Sciences, National Agriculture and Food Research Organization, Ibaraki, Japan.
Nobuyoshi OtoriDepartment of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.
Hiromi KojimaDepartment of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transgenic rice seeds that contain genetically modified Cry j 1 and Cry j 2, the two major allergens of Cryptomeria japonica (Japanese cedar; JC), have been developed as immunotherapeutic candidates for JC pollinosis. Because the transgenic rice (TG-rice) seeds express allergens containing whole amino acid sequences of Cry j 1 and Cry j 2 in the endosperm tissue (edible part of rice grain), they can potentially target all Cry j 1- and Cry j 2-specific T-cells. However, it was unknown whether antigenicity of Cry j 1 and Cry j 2 could be completely preserved in TG-rice seeds. We verified the antigenicity of TG-rice seeds to T-cells through the analysis of the proliferative responses of T-cells in Cry j 1- or Cry j 2-immunized mice or T-cell lines to TG-rice seed extract. First, four mouse strains were immunized with Cry j 1 or Cry j 2. T-cells in the immunized mice proliferated on treatment with TG-rice seed extract, but not non-transgenic wild-type rice (WT-rice) seed extract. Furthermore, T-cell lines were established from the spleen cells of the immunized mice. Each T-cell line resulted in a proliferative response to TG-rice seed extract, but not to WT-rice seed extract, suggesting that TG-rice seeds certainly express T-cell epitopes corresponding to T-cell lines. Considering the modified amino acid sequences of Cry j 1 and Cry j 2 in TG-rice seeds, the expression of specific T-cell epitopes suggested that TG-rice seeds express all possible T-cell epitope repertoires of Cry j 1 and Cry j 2.

Indexed as

AllergensAmino Acid SequenceAnimalsAntigens, PlantCell ProliferationCryptomeriaDisease Models, AnimalEpitopes, T-LymphocyteGene ExpressionImmunizationLymphocyte ActivationMaleMiceMice, Inbred StrainsOryzaPeptide MappingAllergensAntigens, PlantCry j II protein, Cryptomeria japonicaCry j I protein, Cryptomeria japonicaEpitopes, T-LymphocytePlant ExtractsPlant ProteinsimmunotherapypollinosisT-cell epitopeT-cell linetransgenic rice

Identifiers

PMID31323138
PMCPMC6742765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.